Cargando…

A clinicoradiographic assessment of 1% metformin gel with platelet-rich fibrin in the treatment of mandibular grade II furcation defects

BACKGROUND: Management of furcation defects is challenging, and constantly newer therapeutic strategies are evolving. Platelet-rich fibrin (PRF) is successfully used alone and in combination with various agents in the furcation defects. Lately, metformin (MF), a second generation biguanide has gaine...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Parul, Grover, Harpreet Singh, Masamatti, Sujata Surendra, Saksena, Neha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813345/
https://www.ncbi.nlm.nih.gov/pubmed/29456305
http://dx.doi.org/10.4103/jisp.jisp_292_17
_version_ 1783300174996570112
author Sharma, Parul
Grover, Harpreet Singh
Masamatti, Sujata Surendra
Saksena, Neha
author_facet Sharma, Parul
Grover, Harpreet Singh
Masamatti, Sujata Surendra
Saksena, Neha
author_sort Sharma, Parul
collection PubMed
description BACKGROUND: Management of furcation defects is challenging, and constantly newer therapeutic strategies are evolving. Platelet-rich fibrin (PRF) is successfully used alone and in combination with various agents in the furcation defects. Lately, metformin (MF), a second generation biguanide has gained popularity owing to its osteogenic potential. AIMS AND OBJECTIVES: The aim of the present study was to evaluate the clinical and radiographic effectiveness of open flap debridement (OFD) and PRF when compared to OFD + PRF + 1% MF gel in the management of mandibular Grade II furcation defects. MATERIALS AND METHODS: Thirty mandibular grade II furcation defects were stratified into two groups; in one group OFD and PRF is used, and the other group had an additional MF gel with PRF in OFD. Clinical parameters such as plaque index, modified sulcus bleeding index, probing pocket depth (PD), relative vertical attachment level (RVAL), and relative horizontal attachment level (RHAL) were recorded at baseline and at 6 months. Radiovisiography and ImageJ software were used to evaluate the intrabony defect depth. RESULTS: The OFD + PRF + MF group showed significantly higher probing PD reduction, RVAL and RHAL gain than the OFD + PRF group. CONCLUSIONS: PRF when combined with a potential osteogenic agent like MF can provide a better therapeutic benefit to a furcation involved tooth.
format Online
Article
Text
id pubmed-5813345
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58133452018-02-16 A clinicoradiographic assessment of 1% metformin gel with platelet-rich fibrin in the treatment of mandibular grade II furcation defects Sharma, Parul Grover, Harpreet Singh Masamatti, Sujata Surendra Saksena, Neha J Indian Soc Periodontol Original Article BACKGROUND: Management of furcation defects is challenging, and constantly newer therapeutic strategies are evolving. Platelet-rich fibrin (PRF) is successfully used alone and in combination with various agents in the furcation defects. Lately, metformin (MF), a second generation biguanide has gained popularity owing to its osteogenic potential. AIMS AND OBJECTIVES: The aim of the present study was to evaluate the clinical and radiographic effectiveness of open flap debridement (OFD) and PRF when compared to OFD + PRF + 1% MF gel in the management of mandibular Grade II furcation defects. MATERIALS AND METHODS: Thirty mandibular grade II furcation defects were stratified into two groups; in one group OFD and PRF is used, and the other group had an additional MF gel with PRF in OFD. Clinical parameters such as plaque index, modified sulcus bleeding index, probing pocket depth (PD), relative vertical attachment level (RVAL), and relative horizontal attachment level (RHAL) were recorded at baseline and at 6 months. Radiovisiography and ImageJ software were used to evaluate the intrabony defect depth. RESULTS: The OFD + PRF + MF group showed significantly higher probing PD reduction, RVAL and RHAL gain than the OFD + PRF group. CONCLUSIONS: PRF when combined with a potential osteogenic agent like MF can provide a better therapeutic benefit to a furcation involved tooth. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5813345/ /pubmed/29456305 http://dx.doi.org/10.4103/jisp.jisp_292_17 Text en Copyright: © 2018 Indian Society of Periodontology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sharma, Parul
Grover, Harpreet Singh
Masamatti, Sujata Surendra
Saksena, Neha
A clinicoradiographic assessment of 1% metformin gel with platelet-rich fibrin in the treatment of mandibular grade II furcation defects
title A clinicoradiographic assessment of 1% metformin gel with platelet-rich fibrin in the treatment of mandibular grade II furcation defects
title_full A clinicoradiographic assessment of 1% metformin gel with platelet-rich fibrin in the treatment of mandibular grade II furcation defects
title_fullStr A clinicoradiographic assessment of 1% metformin gel with platelet-rich fibrin in the treatment of mandibular grade II furcation defects
title_full_unstemmed A clinicoradiographic assessment of 1% metformin gel with platelet-rich fibrin in the treatment of mandibular grade II furcation defects
title_short A clinicoradiographic assessment of 1% metformin gel with platelet-rich fibrin in the treatment of mandibular grade II furcation defects
title_sort clinicoradiographic assessment of 1% metformin gel with platelet-rich fibrin in the treatment of mandibular grade ii furcation defects
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813345/
https://www.ncbi.nlm.nih.gov/pubmed/29456305
http://dx.doi.org/10.4103/jisp.jisp_292_17
work_keys_str_mv AT sharmaparul aclinicoradiographicassessmentof1metformingelwithplateletrichfibrininthetreatmentofmandibulargradeiifurcationdefects
AT groverharpreetsingh aclinicoradiographicassessmentof1metformingelwithplateletrichfibrininthetreatmentofmandibulargradeiifurcationdefects
AT masamattisujatasurendra aclinicoradiographicassessmentof1metformingelwithplateletrichfibrininthetreatmentofmandibulargradeiifurcationdefects
AT saksenaneha aclinicoradiographicassessmentof1metformingelwithplateletrichfibrininthetreatmentofmandibulargradeiifurcationdefects
AT sharmaparul clinicoradiographicassessmentof1metformingelwithplateletrichfibrininthetreatmentofmandibulargradeiifurcationdefects
AT groverharpreetsingh clinicoradiographicassessmentof1metformingelwithplateletrichfibrininthetreatmentofmandibulargradeiifurcationdefects
AT masamattisujatasurendra clinicoradiographicassessmentof1metformingelwithplateletrichfibrininthetreatmentofmandibulargradeiifurcationdefects
AT saksenaneha clinicoradiographicassessmentof1metformingelwithplateletrichfibrininthetreatmentofmandibulargradeiifurcationdefects